Recent research suggests very few eligible individuals who express interest in a diabetes prevention program are actually referred or participate, despite their effectiveness. Consultant360 spoke with lead...
Recent research suggests very few eligible individuals who express interest in a diabetes prevention program are actually referred or participate, despite their effectiveness. Consultant360 spoke with lead...
Recent research suggests very few eligible individuals who express interest in a diabetes prevention program are actually referred or participate, despite their effectiveness. Consultant360 spoke with lead...
Lead author of the INFINITY trial, William B. White, MD, answers our questions about the preliminary results of the trial and subsequent analyses the team plans to conduct.
Lead author of the INFINITY trial, William B. White, MD, answers our questions about the preliminary results of the trial and subsequent analyses the team plans to conduct.